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Microarray data processing, pathway analysis and hierarchical cluster analysis Genome-wide gene expression analysis was carried out on 1000ng RNA using the Illumina Human-HT-12 v4 Expression BeadChip gene expression platform comprising 47,231 probes. The report for analysis was generated by Illumina's Genomestudio software. Data backgrounds were subtracted and probes that did not have a detection value greater than or equal to 0.95 in at least 5% of samples were removed. The raw data were transformed and normalised using the Variance Stabilisation and Normalisation method. 6 Quality control (QC) checks including principal component analysis (PCA) to identify batch and array effects were carried out using R. 7 Following QC, five samples were removed from the discovery cohort and eight samples from the validation cohort. In addition, in order to assign SRS using the gene expression model, the raw validation data were restricted to probes retained in the original cohort and normalised against the discovery data. Pre-processing, QC checks and statistical analyses were conducted separately for the discovery and validation datasets.
We identified the optimal number of sepsis response signature (SRS) groups (2-4) using within-group sum of squares. Significant associations with early mortality (14-day survival) remained when the number of groups was increased to 3 (P value 0.036) or 4 (P value 0.0015). We therefore selected the minimum number of groups that explained the difference in survival in order to maximize power to detect phenotypic differences between groups.
For a false discovery rate of 0.05 with 3000 genes differentially expressed between SRS groups, the power to detect a 1.5-fold difference in expression between SRS1 and SRS2 with a minimal sample size of 37 patients in one group will be 1. To select predictive gene sets, the data were first restricted to genes with moderate to high expression (log 2 (expression) >6.5 in a proportion of samples which equated to the smallest group of a comparison) and showed >2 fold change (FC) between SRS groups or >1.5FC between survivors and non-survivors. Models with a small number of predictors were then generated using a methodology developed for data sets with many more variables than observations, which fits response models with a sparsity prior and carries out simultaneous variable selection and parameter estimation. 8 R packages 7 used included limma 9 (differential gene expression), FactoMineR 10 (hierarchical clustering) and GeneRave CSIRO Bioinformatics version 3.0.8 8 (to identify clinical covariates or genes for use in prediction models).
Genotyping
Genotyping was performed for 730,525 SNPs using the Illumina HumanOmniExpress BeadChip. PLINK 11 was used for the genotyping QC. Sample QC included discordant sex information, proportion of missing genotypes (>0.02), heterozygosity rate, identity by descent (pi hat >0.1875) and multi-dimensional scaling with 1000 Genomes populations ( Figure S14 ). SNP QC included SNP missing data proportion (>0.02), minor allele frequency (MAF) (<0.01) and HWE (<1x10 -10 ). For both the SRS cluster specific and trans-eQTL analysis, SNPs with MAF < 0.05 were excluded.
eQTL analysis
Following QC, 240 patients within the discovery cohort had good quality genome-wide gene expression and genotyping data for eQTL analysis. We conducted two further QC steps at the probe level to reduce potential confounding effects. Firstly, we excluded probes with sequences that mapped to more than one genomic location using BLAST. Secondly, we excluded probes corresponding to sequences with a SNP present at a MAF of at least 1% in European populations (1000 Genomes Project). eQTL analysis was performed using an additive linear model by the R package Matrix eQTL 12 . We included major principal components (PCs) of the gene expression data as covariates in the eQTL analysis to limit the effect of confounding factors. As noted by other investigators mapping eQTL in different contexts, this enhances detection of eQTLs [13] [14] [15] . The number of PCs to include was determined by mapping cis eQTL with increasing numbers of PCs to maximise the number of unique probes with cis eQTL associations. We included the first 30 PCs for the main eQTL ( Figure S1 ) and the first 25 PCs for the individual SRS group eQTL.
Comparison with whole blood eQTL meta-analysis Sepsis eQTL were compared to the Westra et al eQTL meta-analysis dataset. 15 We restricted the analysis to the 13,590 genes shared across the Illumina Expression BeadChips used and compared the datasets for shared and specific eQTL at the gene level. eQTL were considered likely to be sepsis-specific if no significant association (FDR <0.05) was seen for a given gene in the Westra data.
Annotation of eQTL with epigenomic features
Following exclusion of Y chromosome SNPs, 3,643 unique peak eSNPs showing evidence of sepsis cis-eQTL (FDR<0.05) were annotated with chromatin features for lipopolysaccharide stimulated monocytes from the Blueprint Consortium 16 downloaded from their ftp server. The data included histone marks (H3K27ac, H3K4me1 and H3K4me3) for two samples and DNase I hypersensitivity for four samples. Data were available for all autosomes and the X chromosome. Consensus peaks were defined by presence in at least two samples. The proportion of eSNPs that overlapped with each mark was compared to the proportion for SNPs within 1Mb of a probe (n=614,176) by Fisher's Exact test, and distance to the nearest mark by Mann-Whitney test.
Endotoxin tolerance
Two human endotoxin tolerance datasets were accessed through NCBI GEO database (http://www.ncbi.nlm.nih.gov/geo/), accession GSE15219 and GSE22248. The transcriptomic response to a single lipopolysaccharide treatment was first established. The expression of these lipopolysaccharide response genes in cells stimulated once was then compared to their expression in cells from the same subject that had been treated twice to identify differentially responding genes. Combining these two studies defined an endotoxin tolerance gene signature comprising 398 genes (FDR <0.05, FC >1.5), of which 331 were measured in the sepsis patients. Enrichment of this tolerance signature within the genes differentially expressed between SRS groups was assessed using ROAST 17 , a rotation-based gene set test that takes account of directionality in addition to significance, enabling the likelihood of the SRS1 group expression signature being enriched for the endotoxin tolerance signature to be determined. Coinhibitor   PDCD1  CTLA4 PAG1  PTPRC CD4 CD8A  CD8B  CD3E  CD3G  TRA  TRB  CD3D  LAT  TRAT1 CD28 ICOS  CD40LG  IL-2R -35 , indicating likelihood of the genes in a network being found together due to random chance) identified on network analysis of differentially expressed genes between SRS groups 1 and 2 in the discovery cohort included 35 genes of which HIF1A (HIF1α) and EPAS1 (HIF2α) are nodal genes. Log fold change is shown below molecular symbols together with FDR. (B) Gene expression data for differentially expressed genes in the validation cohort overlaid on the same gene network. Log fold change is shown below molecular symbols together with FDR. (C) Sepsis cis-eQTL involving genes in network (where cis-eQTL are found, molecules are shaded and P values shown). (D) In the validation cohort, the second most significant network identified (P 1x10 -28 ) was also related to hypoxia with HIF1A as a nodal gene and included 9 other genes shared with (a). Log fold change is shown below molecular symbols together with FDR. Figure S4 . NF-κB related network among differentially expressed genes between patient SRS groups. (A) Gene network identified on network analysis of differentially expressed genes between SRS groups 1 and 2 in the discovery cohort included 31 genes with NF-κB complex as the node (individual NF-κB genes shown below nodal network) (P 1x10 -25 ). Log fold change is shown below molecular symbols together with FDR. (B) Gene expression data for differentially expressed genes in the validation cohort overlaid on the same gene network. Log fold change is shown below molecular symbols together with FDR. (C) Sepsis cis-eQTL involving genes in discovery data network (where cis-eQTL are found, molecules are shaded and P values shown). (D) In the validation cohort, the most significant network identified was also related to NF-κB (P 1x10 -28 ) involving 33 genes. Log fold change is shown below molecular symbols together with FDR. Figure S5 . MYC and histone related networks identified among differentially expressed genes between patient SRS groups. In each network log fold change and FDR are shown below molecular symbols. (A) Gene network identified on network analysis of genes differentially expressed between SRS groups in the discovery cohort included 34 genes with MYC as the node (second most significant network identified, P 1x10 -27 ). MYC, a transcription factor involved in cell proliferation, apoptosis and survival, was significantly down-regulated in SRS1 patients, as was the anti-apoptotic gene BCL2, overexpression of which improves survival in sepsis 18 . Expression of the serine/threonine kinase RIP3 (RIPK3) which plays an essential role in necroptosis 19 and its substrate MLKL were increased in SRS1 patients, while BIRC3 encoding cIAP2, a critical inhibitor of necroptosis conferring protection during influenza virus infections 20 , was down-regulated. (B) Gene expression data for differentially expressed genes in the validation cohort overlaid on the same MYC gene network. (C) Gene network identified on network analysis of differentially expressed genes between SRS groups in the discovery cohort included 34 genes with histone H3 gene complex as the node (P 1x10 -27 ). The majority of assayed histone genes were up-regulated in SRS1 patients (all 7 genes with >1.5 FC up-regulated). Extracellular histones have potent toxic effects, notably in the context of neutrophil extracellular traps (NETs) resulting in NETosis, which in the context of sepsis can promote endothelial dysfunction, hypoxia and death 21 . (D) Gene expression data for differentially expressed genes in the validation cohort overlaid on the same histone gene network. Figure S6 . Correlation of differential gene expression between SRS groups in derivation and validation cohorts. The log fold change for differential gene expression of all measured genes between SRS groups 1 and 2 in the validation cohort is plotted against log fold change for the same genes between SRS groups 1 and 2 in the discovery cohort. The log fold changes are highly correlated (r 2 0.82 P <2.2x10 -16 ). . Correlation of differential gene expression between groups in the validation cohort determined using the SRS predictive gene set or an unsupervised clustering approach. The log fold change for differential gene expression of all measured genes between groups determined by unsupervised clustering in the validation cohort is plotted against log fold change for the same genes between SRS groups 1 and 2 defined by our predictive gene set in the same cohort. The log fold changes are highly correlated (r 2 0.84 P <2.2x10 -16 ). 2.1E-7
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2.0E-6 2.3E-5 2.5E-7 This SNP shows a cis-eQTL (P 2.9x10 -7 ) for VPS18 encoding vacuole protein sorting 18, a subunit of the homotypic fusion and vacuole protein sorting complex (HOPS) involved in endocytic and autophagocytic pathways. VPS18 has been shown to be critical to interactions between signalling and membrane trafficking 22 . Related trans associated genes include WASF2 encoding a WAS protein family member involved in transduction of signals relating to cell shape, motility and function; SSR2, encoding signal sequence receptor 2; and MYO1G, encoding plasma membrane myosin IG which is abundant in lymphocytes and involved in Fc-gamma receptor mediated phagocytosis. A,C,E,G) and local regional association plots (B,D,F,H).  (A-B) IL18RAP shows evidence of a cis-eQTL involving rs2110735 (P 3.6x10 -20 FDR 1.7x10 -16 ) and is up-regulated in SRS1 patients (FC 1.9, FDR 3.2x10 -22 
